From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest Views & News

Kerboom! Gotcha! Sinophi statement up throws massive spanner in Advanced Oncotherapy works - Timber!

By Tom Winnifrith, The Sheriff of AIM | Tuesday 29 November 2016


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Advanced Oncotherapy's (AVO) much ramped JV with China based Sinophi is falling apart in the most embarrassing of ways. Advanced announced its first deal with Sinophi on March 25 2015, a statement made by Sinophi should have the FCA and AIM regulation crawling all over this one.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

WIX

How is Wickes getting along?

Friday »

TERN

Tern – Is There More Bad News On The Way?

Thursday »

ZYT

Zytronic – now a recovery Buy?

 

YGEN

Buy Yourgene - target 0.6p

 

ROO

Keep avoiding Deliveroo shares

Friday »

THS

Tharisa – Q1 report, still a value Buy